Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Juno Therapeutics (JUNO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,096,926
  • Shares Outstanding, K 116,110
  • Annual Sales, $ 79,360 K
  • Annual Income, $ -245,580 K
  • 36-Month Beta 3.24
  • Price/Sales 82.93
  • Price/Cash Flow N/A
  • Price/Book 9.58
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.25
  • Most Recent Earnings -0.73 on 11/01/17
  • Next Earnings Date 03/07/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/17
See More
  • Average Estimate -1.13
  • Number of Estimates 4
  • High Estimate -0.67
  • Low Estimate -1.59
  • Prior Year -0.66
  • Growth Rate Est. (year over year) -71.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.77 +2.58%
on 02/20/18
87.01 -0.06%
on 03/05/18
+1.34 (+1.57%)
since 02/05/18
3-Month
42.29 +105.63%
on 12/19/17
87.01 -0.06%
on 03/05/18
+33.76 (+63.46%)
since 12/05/17
52-Week
19.62 +343.22%
on 03/27/17
87.01 -0.06%
on 03/05/18
+65.35 (+302.41%)
since 03/03/17

Most Recent Stories

More News
78.2% Return Seen to Date on SmarTrend Juno Therapeutic Call (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 12 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Juno Therapeutic Has Returned 78.2% Since SmarTrend Recommendation (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 12 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Multiverse Investment Fund Begins Operations in West Los Angeles

Multiverse Investment Fund I, LP (Multiverse) (http://www.multiverseinvestmentfund.com) a venture fund geared to investing in gatekeeper bio and high tech companies with potential for significant...

CELGZ : 0.81 (+8.00%)
JUNO : 86.96 (+0.10%)
78.2% Return Seen to Date on SmarTrend Juno Therapeutic Call (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 12 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Juno Therapeutic Shares Up 78.2% Since SmarTrend's Buy Recommendation (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 11 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Eureka Therapeutics Announces Data Presentations Validating Its Proprietary E-ALPHA Discovery Platform at the 2018 ASH Annual Meeting

--BCMA/multiple myeloma CAR-T program licensed to Juno Therapeutics (now Celgene)

JUNO : 86.96 (+0.10%)
Juno Therapeutic Up 78.2% Since SmarTrend Uptrend Call (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 11 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
78.2% Return Seen to Date on SmarTrend Juno Therapeutic Call (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 10 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
Juno Therapeutic Shares Up 78.2% Since SmarTrend's Buy Recommendation (JUNO)

SmarTrend identified an Uptrend for Juno Therapeutic (NASDAQ:JUNO) on January 5th, 2018 at $48.79. In approximately 10 months, Juno Therapeutic has returned 78.23% as of today's recent price of $86.96....

JUNO : 86.96 (+0.10%)
FogPharma Appoints Dr. Barbara Weber to its Board of Directors

FogPharma today announced that Barbara Weber, M.D., will join its board of directors. Dr. Weber is president and CEO of Tango Therapeutics and venture partner at Third Rock Ventures. She has served as...

JUNO : 86.96 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade JUNO with:

Business Summary

Juno Therapeutics, Inc. is a biopharmaceutical company. The Company develops cellular immunotherapies based on two platforms - Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Its clinical CD19 product candidates include JCAR015 that is in Phase I clinical trials for adult...

See More

Key Turning Points

2nd Resistance Point 87.07
1st Resistance Point 87.01
Last Price 86.96
1st Support Level 86.90
2nd Support Level 86.85

See More

52-Week High 87.01
Last Price 86.96
Fibonacci 61.8% 61.27
Fibonacci 50% 53.32
Fibonacci 38.2% 45.36
52-Week Low 19.62

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar